Consortium including ElsaLys Biotech and Novadiscovery awarded €3.35 million by Bpifrance to advance inolimomab in graft-versus-host disease

NEXT STORY
Global Vaccine Market (2020 to 2027) – by Technology, Indication, and End-use
PREV STORY
Dr. Henry Ji to Participate in a Fireside Chat at the B. Riley Securities Oncology Investor Conference on Jan 20, 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chembio Diagnostics Provides Update on FDA Submission of DPP HIV-Syphilis Test

author_avatar
NASDAQ Market News

Agios to Present at the RBC Capital Markets Global Healthcare Virtual Conference on Tuesday, May 19, 2020

author_avatar
NASDAQ Market News

Checkpoint Therapeutics to Participate in June Investor Conferences

NEW YORK, June 04, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ:CKPT), a ...

author_avatar
NASDAQ Market News